SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-036401
Filing Date
2023-11-02
Accepted
2023-11-02 16:12:10
Documents
68
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ngm-20230930.htm   iXBRL 10-Q 1324147
2 EX-10.1 ngm-20230930xex101offerlet.htm EX-10.1 40579
3 EX-10.2 ngm-20230930xex102lonzaame.htm EX-10.2 56087
4 EX-31.1 ngm-20230930x10qex311.htm EX-31.1 11094
5 EX-31.2 ngm-20230930x10qex312.htm EX-31.2 10852
6 EX-32.1 ngm-20230930x10qex321.htm EX-32.1 8041
12 GRAPHIC image_0.jpg GRAPHIC 26992
13 GRAPHIC lonza_logo.jpg GRAPHIC 18271
  Complete submission text file 0001628280-23-036401.txt   6281807

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngm-20230930.xsd EX-101.SCH 37502
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ngm-20230930_cal.xml EX-101.CAL 47886
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ngm-20230930_def.xml EX-101.DEF 181176
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngm-20230930_lab.xml EX-101.LAB 608094
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngm-20230930_pre.xml EX-101.PRE 363567
62 EXTRACTED XBRL INSTANCE DOCUMENT ngm-20230930_htm.xml XML 741502
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38853 | Film No.: 231372432
SIC: 2834 Pharmaceutical Preparations